Prognostic indices of perioperative outcome following transperitoneal laparoscopic adrenalectomy

J Laparoendosc Adv Surg Tech A. 2014 Aug;24(8):528-33. doi: 10.1089/lap.2014.0048.

Abstract

Objectives: We sought to identify preoperative patient and tumor characteristics that may be useful prognostic indicators of postsurgical outcome in patients undergoing laparoscopic adrenalectomy (LA).

Subjects and methods: Data from 92 patients who underwent 93 transabdominal LA procedures between 2006-2012 were retrieved. Patients were stratified based on estimated blood loss (EBL), length of stay (LOS), and perioperative complications. Interdependencies between surgical outcome and patient demographics, tumor characteristics, comorbidities, and Charlson Comorbidity Index (CCI) were statistically analyzed. The predictive capacity of each index was assessed using receiver operating characteristic curves.

Results: Neither age, gender, tumor laterality, body mass index, American Society of Anesthesiologists (ASA) score, nor CCI predicted the occurrence of perioperative complications. EBL was significantly associated with increased age, tumor size, ASA score, and CCI, whereas prolonged LOS was associated with higher ASA score. Tumor size was related, although not significantly, to LOS and perioperative complications. Tumors ≥7.5 cm in diameter were significantly associated with worse perioperative outcomes.

Conclusions: LA for adrenal lesions demonstrated reasonable complication rates and perioperative outcomes. Tumor size, CCI, and ASA score are predictive of increased EBL and LOS.

Publication types

  • Evaluation Study

MeSH terms

  • Adrenal Gland Neoplasms / pathology
  • Adrenal Gland Neoplasms / surgery*
  • Adrenalectomy / methods*
  • Blood Loss, Surgical / statistics & numerical data
  • Body Mass Index
  • Comorbidity
  • Female
  • Humans
  • Incidence
  • Laparoscopy / methods*
  • Length of Stay
  • Male
  • Middle Aged
  • Postoperative Complications / epidemiology
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Treatment Outcome